Keyphrases
Liposomes
57%
Liposomal
43%
Nanodrug
42%
Methylprednisolone
41%
Prodrug
35%
PEGylated Nanoliposome
30%
Sterically Stabilized Liposomes
28%
Nanoliposomes
25%
Weak Acid
24%
Therapeutic Efficacy
23%
Inflammation
19%
Steroidal
19%
Foreign Body
17%
Comirnaty
17%
SARS-CoV-2 Vaccine
17%
Polyethylene Glycol
14%
Lipids
13%
Nanomedicine
13%
Anti-inflammatory Agents
13%
Infusion Reaction
12%
Complement Activation
12%
Phosphatidylcholine Liposomes
11%
MRNA-LNP
11%
Inflammatory Cytokines
10%
First Dose
10%
Inflammatory Diseases
10%
A-Si
10%
Arthritis
9%
PEGylated
9%
Nanoparticles
9%
Lipid Nanoparticles
9%
Doxorubicin
9%
Polyethylene Glycol Antibodies
8%
Comirnaty Vaccine
8%
Lipid Complex
8%
Low Friction Coefficient
8%
On-a-chip
8%
Close-packed
8%
Multi-organ
8%
Hydrogen Bonds (H-bonds)
8%
Free Drug
8%
Experimental Cerebral Malaria
8%
Boundary Lubricant
8%
COVID-19 Vaccine
8%
Release Rate
8%
3D Printing
8%
Acute Symptoms
8%
Neurodegenerative Diseases
8%
Ultrasound-triggered Release
8%
Cellular Water Content
8%
Pharmacology, Toxicology and Pharmaceutical Science
Liposome
100%
Glucocorticoid
47%
Methylprednisolone Sodium Succinate
37%
Prodrug
32%
Combination Therapy
22%
Inflammation
21%
Messenger RNA
19%
Diseases
17%
Foreign Body
17%
Macrogol
17%
COVID-19 Vaccine
17%
Nanomedicine
17%
Doxorubicin
17%
Cytokine
15%
Antiinflammatory Agent
13%
Allergic Reaction
12%
Inflammatory Arthritis
12%
Rheumatoid Arthritis
12%
Nanoparticle
11%
Arthritis
10%
Inflammatory Disease
10%
Solid Lipid Nanoparticle
10%
Mouse Model
9%
Cisplatin
8%
Neoplasm
8%
Elimination
8%
Degenerative Disease
8%
Adjuvant-Induced Arthritis
8%
Cerebral Malaria
8%
Infection
8%
Clinical Study
8%
Adjuvant Arthritis
8%
Implant
8%
Macrogol Derivative
8%
Duchenne Muscular Dystrophy
8%
Zirconium 89
8%
Polyethylene Terephthalate
8%
Styrofoam
8%
Cartilage Degeneration
8%
Adverse Event
7%
Biodistribution
7%
Experimental Autoimmune Encephalomyelitis
6%
Pulmonary Hypertension
6%
Anaphylaxis
6%
Pharmacokinetic
6%
Osteoarthritis
6%
Side Effect
5%
Drug Release
5%
Tumor Necrosis Factor
5%